Sensimed | search
Click here to view Sensimed news from 60+ newspapers.
Bookmark or Share- Sensimed announces the acquisition of majority interest by SEED CO., LTDCO., LTD has acquired a majority stake in Sensimed. The transaction officially closed on Friday 29th November with SEED now owning over 90% of outstanding shares. The two Companies have a successful collaborative history. In August 2013 SEED CO., LTD became a commercial partner in Japan and invested in Sensimed by way of a loan. They worked
- SENSIMED Triggerfish may help to assess glaucoma treatment efficacySENSIMED Triggerfish® is a non-implantable device capable of identifying the peak pattern related to IOP changes outside office hours. The device may detect changes in IOP-related pattern resulting from glaucoma therapy beyond daytime GAT IOP, and could be used to assess the efficacy of different glaucoma treatments, especially during the night,
- Technical white paper - SensimedThe SENSIMED Triggerfish® Sensor device developed by Sensimed AG is a contact lens capable of capturing spontaneous circumferential changes at the corneoscleral area over a 24 hour period.
- Who we are – Sensimed S.A.Sensimed SA, a Swiss company, has developed a unique non-invasive soft contact lens-based solution, the SENSIMED Triggerfish ® , with the aim of revolutionizing glaucoma management by providing an automated recording of continuous ocular dimensional change over 24 hours.
- News – Sensimed S.A.Sensimed is pleased to announce the registration of the SENSIMED Triggerfish® sensor and monitoring system as a medical device in Japan. The Japanese partner and distributor of Sensimed, SEED Co., Ltd., has obtained the approval from the Ministry of Health, Labour and Welfare.
More
